Labs / ADME, DMPK & toxicology
Coriolis Pharma
Martinsried, Germany · coriolis-pharma.com
GMP
Coriolis Pharma provides drug product development, analytical services, and manufacturing services for biopharmaceutical products. It serves pharmaceutical and biotech partners from preclinical through commercialization under R&D and GMP conditions, with headquarters in Martinsried near Munich and a U.S. office in Durham, North Carolina.
They take quote requests through a form on their website with project details. Their quote form
What they offer
Drug Product Development Accelerator Development Platforms
Standardized development platform services intended to speed Phase I clinical trial readiness and support developability and formulatability assessment.
In Silico Modeling
AI- and data-driven modeling to assess molecule behavior early and support development decisions.
Preformulation Studies
Developability assessment and preformulation screening to identify suitable formulation conditions before first-in-human development.
Formulation Development Services
Development of robust liquid, frozen, and lyophilized formulations for biopharmaceutical drug products.
Comparability Studies
Studies to compare product or process changes during development and lifecycle management.
Stability Studies
Stability testing services for development, release, and commercialization needs.
In-Use Stability Studies
Assessment of stability after product use or preparation for administration.
Forced Degradation Studies
Studies designed to intentionally stress drug products to understand degradation behavior.
Biopharmaceutical Process Development
Process development support for biopharmaceutical drug products and related development challenges.
Wet-Lab Developability and Formulatability Assessment
Laboratory assessment of molecule developability and formulation suitability.
Fast-Track Analytics
Rapid analytical testing services for development-stage biopharmaceuticals.
Method Development and Validation
Development and validation of analytical methods for R&D and GMP use.
Aggregate Analytics
Analytical characterization of aggregates in biologics.
Particle Characterization
Characterization of particles in biopharmaceutical samples.
Particle Identification
Identification of particles detected in samples.
Surfactant Characterization
Analysis of surfactants used in formulations.
Higher-Order Structure Analysis
Analysis of higher-order structure in biotherapeutic molecules.
Functional Assays
Bioactivity or function-based assays for biologics.
Chemical Change Analysis
Analysis of chemical changes in drug products or biomolecules.
Container Closure and Integrity Testing
Testing of container closure integrity for drug products.
What they work on
- Modalities
- Antibody, Peptide, Viral vector, Cell therapy, Vaccine
- Assays and studies
- aggregate analytics, particle characterization, particle identification, surfactant characterization, higher-order structure analysis, functional assays, chemical change analysis, container closure integrity testing, basic formulation characterization, stability testing, release testing, method development and validation, and 2 more
- Instruments and platforms
- analytical ultracentrifugation (AUC), HPLC
- Scale and capacity
- 3,600+ sqm R&D and GMP lab space, 200+ analytical devices, automated filling line, manual filling capacities, non-GMP manufacturing and lyophilization capabilities
- Type
- CRO
- Sites
- Martinsried, Germany · Durham, NC, United States
- Quality
- GMP conditions · biosafety levels 1 and 2 · FDA Inspection Without Observations
- Serves
- global
- Address
- 8 Davis Drive, Suite 324 Durham, NC 27713, United States
Public records
Similar labs. Esco Aster, VxP Biologics, Biofidus GmbH, Desentum
Found in a contract services directory. Listing built from coriolis-pharma.com. Work here? Claim this listing.